Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp
Bullboard Posts
User Avatar Image
(3)
•••
Comment by PotBeforeLiquoron Jun 26, 2020 11:56am
208 Views
Post# 31195561

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Don't forget this IPO'd at $0.15 per share

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Don't forget this IPO'd at $0.15 per shareThe indsutry is real, this company IMO is #1 in the indsutry in terms of brand/company recgonition, thus the hype is real.

I don't care how I make money in the market, just because it's hype doesn't make it any less of an investment.  One NR, one event... it crushes the shorts and that floods the stock with money that wouldn't have been there otherwise.  

There's greed on both sides and based on my own opinion and experience, this is setting up for a short squeeze if there is a material NR coming and I believe there will be.  I wouldn't be here if I didn't think this was going somewhere. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities